Guiding Competitive Binding Assays Using Protein-Protein Interaction Prediction: The HER2-Affitin Use Case

Anna Ranaudo1, Ugo Cosentino1, Claudio Greco1

  • 1Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy.

ACS Omega
|December 23, 2024
PubMed
Summary

Engineered affitins show promise for cancer imaging by targeting human epidermal growth-factor receptor 2 (HER2). Computational modeling reveals their binding sites, aiding development of new diagnostic tools and therapies.